| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2014-08-19 | certain assets of Transgenic Rabbit Models - previously known as BioProtein Technologies - (France) including founder rabbits, alpha-glucosidase, alpha-galactosidase, Beta-cerebrosidase, Factor VIII, Factor IX | Pharming (The Netherlands) | € 0.5 million | Rare diseases Technology - Services |
| 2014-08-19 | Corvette Pharmaceutical Services (Italy) | Recipharm (Sweden) | SEK 1.1 billion (€120.1 million) | CDMO |
| 2014-08-14 | lentiviral vector manufacturing business and related assets from Lentigen (USA - MD) | Miltenyi Biotec (Germany) | undisclosed | Cell therapy Gene therapy |
| 2014-08-13 | inhaled therapy platform from Pulmagen Therapeutics (UK) | Skyepharma (UK) | Respiratory diseases |
|
| 2014-08-11 | InoCard (Germany) | uniQure (The Netherlands) | €3 million and success-based milestones and royalties. | Gene therapy Cardiovascular diseases |
| 2014-08-05 | Cardinal Systems (France) | Venn Life Sciences (Ireland) | €672,780 | |
| 2014-08-04 | Santaris Pharma (Denmark) | Roche (Switzerland) | up to $450 million (€ 336 million) | Antisense therapeutics |
| 2014-08-04 | Reinnervate (UK) | Reprocell (Japan) | undisclosed | stem cell products |
| 2014-08-01 | Vancocin®, vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm and vancomycin hydrochloride oral solution 250 mg and 500 mg- Shire (UK - USA) | ANI Pharmaceuticals (Israel) | $11 million | Generic drugs |
| 2014-07-31 | Rottapharm (Italy) | Meda (Sweden) | SEK 21.2 billion (€2.275 billion) | Specialty pharmaceuticals OTC |
| 2014-07-31 | Altacor (UK) | Esperante (The Netherlands) | undisclosed | Ophtalmological diseases Ophtalmology |
| 2014-07-30 | Baxter\'s commercial vaccines business (USA - IL) | Pfizer (USA - NY) | $635 million | Vaccines |
| 2014-07-28 | Penn Pharmaceutical Services (UK) | Packaging Coordinators (USA - PA) | £127 million (€159.8 million - $215.6 million) | services CRO CDMO |
| 2014-07-27 | Clinuvel Pharmaceuticals (Australia) | Retrophin (USA) | ||
| 2014-07-24 | Unisensor (Denmark) | Philips (The Netherlands) | undisclosed | Diagnostics |
| 2014-07-24 | Biocad (Russia) | OJSC Pharmstandard (Russia) | undisclosed | |
| 2014-07-21 | Labrys Biologics (USA) | Teva (Israel) | up to $825 million | CNS diseases |
| 2014-07-21 | Alergo Pharma (Argentina) | Stallergènes (France) | undisclosed | Allergic diseases Respiratory diseases |
| 2014-07-21 | Platine Pharma Services (France) | Advanced BioScience Laboratories (ABL) (USA - MD), part of the Institut Mérieux | undisclosed | CRO Technology - Services Immunology |
| 2014-07-20 | InnoPharma (USA - NJ) | Pfizer (USA - NY) | up to $ 360 million (€ 265.2 million) | Generic drugs Ophtalmological diseases |
